EP-7041, a Factor XIa Inhibitor as a Potential Antithrombotic Strategy in Extracorporeal Membrane Oxygenation: A Brief Report

OBJECTIVES: Current approaches to systemic antithrombotic therapy in support of extracorporeal membrane oxygenation are limited and are hampered by both thrombotic and hemorrhagic complications. An alternative approach is needed. DESIGN: Inhibition of coagulation factor XI/activated factor XI is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollack, Charles V., Kurz, Michael A., Hayward, Neil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498136/
https://www.ncbi.nlm.nih.gov/pubmed/32984829
http://dx.doi.org/10.1097/CCE.0000000000000196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498136/
https://www.ncbi.nlm.nih.gov/pubmed/32984829
http://dx.doi.org/10.1097/CCE.0000000000000196

Ejemplares similares